PMD Solutions

Industry
Medical Devices
Founded Year
2011
Headquarters
Cork, Ireland
Employee Count
29

Key People

  • Myles Murray - Founder & CEO
  • Tom Meagher - Chief Financial Officer
  • Anne Dorney - Chief Compliance Officer & Board Member
  • Ian Yeeles - Chief Commercial Officer
  • Peter Donnelly - Chairman of the Board

Assessment

Team
Aspect: First-time 10+ yrs
Summary: Led by founder and CEO Myles Murray, PMD Solutions has a leadership team with significant experience in the medical device industry.

The leadership team, including CEO Myles Murray, brings over a decade of experience in the medical device sector, which is crucial for product development, regulatory compliance, and market penetration.

Clinical Need
Aspect: Very Strong
Summary: RespiraSense addresses a critical need for continuous respiratory monitoring to detect patient deterioration early.

RespiraSense offers continuous monitoring of respiratory rates, aiding in the early detection of patient deterioration, which is essential in preventing respiratory failure and adverse outcomes.

Competition
Aspect: Somewhat crowded
Summary: The respiratory monitoring market has several players, but RespiraSense's unique features provide a competitive edge.

The respiratory monitoring device market includes multiple competitors; however, RespiraSense's continuous and motion-tolerant monitoring capabilities offer a distinct advantage.

Technical Challenge
Aspect: Moderate
Summary: Developing a continuous, motion-tolerant respiratory monitor involves moderate technical challenges.

Creating a device like RespiraSense requires addressing challenges related to continuous monitoring and motion tolerance, which are significant but achievable with the right expertise.

Patent
Aspect: Strong
Summary: PMD Solutions holds multiple patents, providing strong intellectual property protection.

With 11 patents, including 6 granted and 5 pending, PMD Solutions has established a strong IP foundation that protects its innovations and supports market exclusivity.

Financing
Aspect: Medium
Summary: The company has secured funding, including participation in the DigitalHealth.London Accelerator program.

Participation in accelerator programs and securing funding are positive indicators; however, scaling operations and market expansion may require further financial resources.

Regulatory
Aspect: 510k/PMA
Summary: RespiraSense has obtained CE marking and FDA clearance, indicating strong regulatory progress.

Obtaining CE marking and FDA clearance demonstrates compliance with stringent regulatory standards, facilitating market access in Europe and the United States.

Opportunity Rollup

Odds of Success
3.85
Peak Market Share
5.2
Segment CAGR
3.4%
Market Segment
Anesthesia and Respiratory Devices
Market Sub Segment
Respiratory Monitoring Devices
Year Post Launch Market Penetration (%)
1 0.26
2 0.78
3 1.82
4 3.64
5 5.20

Key Takeaway

PMD Solutions, with its innovative RespiraSense device, is well-positioned to address a critical clinical need in respiratory monitoring, supported by strong leadership and a solid patent portfolio.